glp-1 gastric stasis class action in kentucky Gastric-emptying effects of short-acting versus longer-acting GLP-1 receptor agonists and next-generation
Description
Regul Pept 2001;102:8186
[DOI] [PMC free article] [PubMed] [Google Scholar] 38.Knudsen L.B., Secher A., Hecksher-Srensen J., Pyke C
How may gip enhance the therapeutic efficacy of glp-1
Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial
The results revealed 23 tumors (48%) with positive-GLP-1R expression and 25 tumors (52%) with negative-GLP-1R expression (Table I)
